News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Understanding Adjuvant Therapy in Melanoma

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Robert Alter

Patients With Thyroid Cancer Can Discuss Clinical Trials ‘From the Get-Go’

ByDr. Robert Alter

January 20th 2026

Image of leg.

FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma

BySpencer Feldman

January 20th 2026

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful contributions to others’ lives.

Humility and Impact in Joe McDonough’s Blood Cancer Heroes Experience

ByJoe McDonough

January 20th 2026

cancer survivor

Cancer X 4

ByMary-Elen Benoit

January 19th 2026

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal cancer care.

Understanding the Role of Artificial Intelligence in Gastrointestinal Cancer Care

ByDr. William A. Hall

January 19th 2026

Trending on CURE

Understanding the Role of Artificial Intelligence in Gastrointestinal Cancer Care

How Tecvayli With Darzalex Works to Treat Multiple Myeloma

Highlighting Real-World Data on Immunotherapy Use in Advanced Gastric Cancer

Finding My Power of One After Cancer

Epkinly Improves Progression-Free Survival in Relapsed/Refractory DLBCL